Literature DB >> 22632707

Pharmaceutical therapy for osteoarthritis.

David S Cheng1, Christopher J Visco.   

Abstract

There are a variety of oral and topical pharmaceutical agents for the treatment of osteoarthritis. To date there is no pharmacologic agent proved to prevent disease progression. This article focuses primarily on the medications used for symptomatic relief and palliation of pain. The article reviews the medications' mechanisms of action and the available efficacy literature, as well as indications, contraindications, and common adverse effects.
Copyright © 2012 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22632707     DOI: 10.1016/j.pmrj.2012.02.009

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  23 in total

1.  Osteoarthritis: A Critical Review.

Authors:  Kentaro Onishi; Amol Utturkar; Eric Chang; Richard Panush; Justin Hata; Danielle Perret-Karimi
Journal:  Crit Rev Phys Rehabil Med       Date:  2012

2.  Mitoprotective therapy prevents rapid, strain-dependent mitochondrial dysfunction after articular cartilage injury.

Authors:  Lena R Bartell; Lisa A Fortier; Lawrence J Bonassar; Hazel H Szeto; Itai Cohen; Michelle L Delco
Journal:  J Orthop Res       Date:  2019-12-25       Impact factor: 3.494

3.  Mitochondrial dysfunction is an acute response of articular chondrocytes to mechanical injury.

Authors:  Michelle L Delco; Edward D Bonnevie; Lawrence J Bonassar; Lisa A Fortier
Journal:  J Orthop Res       Date:  2017-07-31       Impact factor: 3.494

4.  Mitoprotective therapy preserves chondrocyte viability and prevents cartilage degeneration in an ex vivo model of posttraumatic osteoarthritis.

Authors:  Michelle L Delco; Edward D Bonnevie; Hazel S Szeto; Lawrence J Bonassar; Lisa A Fortier
Journal:  J Orthop Res       Date:  2018-02-22       Impact factor: 3.494

Review 5.  Post-traumatic osteoarthritis of the ankle: A distinct clinical entity requiring new research approaches.

Authors:  Michelle L Delco; John G Kennedy; Lawrence J Bonassar; Lisa A Fortier
Journal:  J Orthop Res       Date:  2016-11-08       Impact factor: 3.494

6.  Treatment of Posttraumatic Osteoarthritis Secondary to a Chronic Plafond Fracture: A Case Report.

Authors:  Richard E Bechert
Journal:  J Chiropr Med       Date:  2020-08-21

7.  Arthroscopic Debridement and Autologous Micronized Adipose Tissue Injection in the Treatment of Advanced-Stage Posttraumatic Osteoarthritis of the Ankle.

Authors:  Yoshiharu Shimozono; John F Dankert; John G Kennedy
Journal:  Cartilage       Date:  2020-08-06       Impact factor: 3.117

8.  Protective effects of Nebivolol against interleukin-1β (IL-1β)-induced type II collagen destruction mediated by matrix metalloproteinase-13 (MMP-13).

Authors:  Zhigang Li; Baoyi Liu; Dewei Zhao; BenJie Wang; Yupeng Liu; Yao Zhang; Fengde Tian; Borui Li
Journal:  Cell Stress Chaperones       Date:  2017-05-17       Impact factor: 3.667

9.  Green tea polyphenol treatment is chondroprotective, anti-inflammatory and palliative in a mouse post-traumatic osteoarthritis model.

Authors:  Daniel J Leong; Marwa Choudhury; Regina Hanstein; David M Hirsh; Sun Jin Kim; Robert J Majeska; Mitchell B Schaffler; John A Hardin; David C Spray; Mary B Goldring; Neil J Cobelli; Hui B Sun
Journal:  Arthritis Res Ther       Date:  2014-12-17       Impact factor: 5.156

10.  Quercetin Alleviates Osteoarthritis Progression in Rats by Suppressing Inflammation and Apoptosis via Inhibition of IRAK1/NLRP3 Signaling.

Authors:  Wenjun Li; Yeyang Wang; Yaqin Tang; Hanyu Lu; Yong Qi; Guitao Li; Hebei He; Fanglian Lu; Yixin Yang; Hongtao Sun
Journal:  J Inflamm Res       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.